Human adipocyte proteomics - A complementary way of looking at fat

Pharmacogenomics

Volumn 1, Issue 2, 2000, Pages 179-185

  Halvorsen, Yuan Di C ^a   Wilkison, William O ^a   Briggs, Michael R ^a,b  

^a Zen Bio Inc   (United States)

^b PFIZER INC   (United States)

Author keywords

Adipose; Energy homeostasis; Human adipocyte leptin; Proteomics

Indexed keywords

RODENTIA;

HORMONE; PROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL; CYTOLOGY; HUMAN; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; REVIEW;

ADIPOCYTES; ADIPOSE TISSUE; ANIMALS; HORMONES; HUMANS; LIPID METABOLISM; PROTEINS;

EID: 0034189096     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.1.2.179     Document Type: Review

References (57)

1. APFELBAUM M, BRIGANT L: Arguments in favor of an adipostat. Monograph (1976):187-197. An early view of adipose's role in maintenance of energy balance.
2. RAMSAY TG: Fat cells. Endocrinol. Metab. Clin. North Am. (1996) 25(4):847-870.
3. GIRARD J, FERRE P, FOUFELLE F: Mechanisms by which carbohydrates regulate expression of genes for glycolytic and lipogenic enzymes. Ann. Rev. Nutr. (1997) 17:325-352.
4. THORBURN AW, PROIETTO J: Neuropeptides, the hypothalamus and obesity: insights into the central control of body. Pathology (1998) 30(3):229-236.
5. LOFTUS TM: An adipocyte-central nervous system regulatory loop in the control of adipose homeostasis. Semin. Cell Dev. Biol. (1999) 10(1):11-18.
6. AILHAUD G, GRIMALDI P, NEGREL R: Cellular and molecular aspects of adipose tissue development. Ann. Rev. Nutr. (1992) 12:207-233. A review of various events during adipose formation.
7. CRANDALL DL, HOUSMAN GJ, KRAL JG: A review of the microcirculation of adipose tissue: anatomic, metabolic and angiogenic perspectives. Microcirculation (1997) 4(2):211-232.
8. CORNELIUS P, MACDOUGALD OA, LANE MD: Regulation of adipocyte development. Ann. Rev. Nutr. (1994) 14:99-129. A thorough review of factors regulated during adipocyte differentiation.
9. SPIEGELMAN BM, FLIER JS: Adipogenesis and obesity: rounding out the big picture. Cell (1996) 87(3):377-389. A retrospective review of adipose development and obesity.
10. MORRISON RF, FARMER SR: Insights into the transcriptional control of adipocyte differentiation. J. Cell. Biochem. (1999) 75(S32):59-67.
11. ZHOU L, HALVORSEN Y, CRYAN E, PELTON P, BURRIS T, DEMAREST K: Analysis of the pattern of gene expression during human adipogenesis by DNA microarray. Bio. Tech. (1999) 13:513-517.
12. SIDHU RS: Two-dimensional elecgtrophoretic analyses of proteins synthesized during differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. (1979) 254(21):11111-11118.
13. SPIEGELMAN BM, GREEN H: Control of specific protein biosynthesis during the adipose conversion of 3T3 cells. J. Biol. Chem. (1980) 255(18):8811-8818. An early study of adipocyte differentiation.
14. COOK KS, HUNT CR SPIEGELMAN BM: Developmentally regulated mRNAs in 3T3-adipocytes: analysis of transcriptional control. J. Cell. Biol. (1985) 100(2):514-520.
15. SCHERER PE, BICKEL PE, KOTLER M, LODISH HF: Cloning of cell-specific secreted and surface proteins by subtractive antibody screening. Nature Biotechnol. (1998) 16(6):5481-5486. A thorough examination of adipocyte secreted factors.
16. SCHERER PE, WILLIAMS S, FOGLIANO M, BALDINI G, LODISH HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem. (1995) 270(45):26746-26749.
17. HU E, LIANG P, SPIEGELMAN BM: AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. (1996) 271(18):10697-10703.
18. ZHANG Y, PROENCA R, MAFFEI M, BARONE M, LEOPOLD L, FRIEDMAN JM: Positional cloning of the mouse obese gene and its human homologue. Nature (1994) 372:425-432. The milestone of leptin discovery.
19. COLEMAN RA, HERRMANN TS: Nutritional regulation of leptin in humans. Diabetologia (1999) 42(6):639-646.
20. MANTZOROS CS: The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med. (1999) 130(8):671-680. A review of leptin and human obesity which is quite different from a leptin-deficient rodent model.
21. WILM M, SHEVCHENKO A, HOUTHAEVE T et al.: Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature (1996) 379(6564):466-469. The technology of protein identification at femtomole quantity.
22. SHEVCHENKO A, WILM M, VORM O, MANN M: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. (1996) 68(5):850-858. An important tool for studying proteomics using 2D PAGE.
23. BERNDT P, HOBOHM U, LANGEN H: Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints. Electrophoresis (1999) 20(18):3521-3526.
24. ARCH JR, WILSON S: Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes. Int. J. Obes. Relat. Metab. Disord. (1996) 20(3):191-199. An excellent review of using beta3 adrenoceptor agonist for treating obesity.
25. KOLACZYNSKI JW, NYCE MR, CONSIDINE RV et al.: Acute and chronic effects of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes (1996) 45(5):699-701.
26. KWON HY, BULTMAN SJ, LÖFFLER C et al.: Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc. Natl. Acad. Sci. USA (1994) 91(21):9760-9764.
27. MICHAUD EJ, MYNATT RL, MILTENBERGER RJ et al.: Role of the agouti gene in obesity. J. Endocrinol. (1997) 155(2):207-209.
28. GALITZKY J, LAFONTAN M, NORDENSTROM J, ARNER P: Role of vascular alpha-2 adrenoceptors in regulating lipid mobilization from human adipose tissue J Clin. Invest. (1993) 91(5):1997-2003.
29. FRIED SK, BUNKIN DA, GREENBERG AS Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. (1998) 83(3):847-850. An excellent study of human adipose depot variation.
30. MONTAGUE CT, PRINS JB, SANDERS L et al.: Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes (1998) 47(9):1384-1391. A study documenting human adipose depot variations.
31. ADAMS M, MONTAGUE CT, PRINS JB et al.: Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. J. Clin. Invest. (1997) 100(12):3149-3153.
32. GOTTSCHLING-ZELLER H, BIRGEL M, SCRIBA D, BLUM WF, HAUNER H: Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factor-alpha and transforming growth factor-beta1. Eur. J. Endocrinol. (1999) 141(4):436-442. A study of subcutaneous and omental adipose response to growth factors.
33. HAUNER H, ENTENMANN G, WABITSCH M et al.: Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. (1989) 84(5):1663-1670. Established human adipocyte precursor cell differentiation in vitro.
34. ZILBERFARB V, PIETRI-ROUXEL F, JOCKERS R et al.: Human immortalized brown adipocytes express functional beta3-adrenoceptor coupled to lipolysis. J. Cell. Sci. (1997) 110(Pt 7):801-807.
35. HOFFSTEDT J, ARNER P, HELLERS G, LONNQVIST F: Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J. Lipid. Res. (1997) 38(4):795-804.
36. AXELROD L, MINNICH AK, RYAN CA: Stimulation of prostacyclin production in isolated rat adipocytes by angiotensin II, vasopressin and bradykinin: evidence for two separate mechanisms of prostaglandin synthesis. Endocrinology (1985) 116(6):2548-2553.
37. PRINS JB, O'RAHILLY S, CHATTERJEE VK: Steroid hormones and adipose tissue Eur. J. Clin. Invest. (1996) 26(4):259-261.
38. DOBSON DE, KAMBE A, BLOCK E et al.: 1-Butyrylglycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell (1990) 61(2):223-230.
39. HALVORSEN YC, BURSELL S, WILKISON WO et al.: Vasodilation of retinal microvessels induced by monobutyrin: Dysregulation in diabetes. J. Clin. Invest. (1993) 92:2872-2876.
40. GRIMALDI PA: Roles of lipid-activated receptors in the adipogenic action of fatty acids. Lipids (1999) 34(Suppl.):S205-S208.
41. KARLSSON C, LINDELL K, OTTOSSON M, SJOSTROM L, CARLSSON B, CARLSSON LM: Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J. Clin. Endocrinol. Metab. (1998) 83(11):3925-3929.
42. ZECHNER R, MOSER R, NEWMAN TC, FRIED SK, BRESLOW JL: Apolipoprotein E gene expression in mouse 3T3-L1 adipocytes and human adipose tissue and its regulation by differentiation and lipid content. J. Biol. Chem. (1991) 266(16):10583-10588.
43. GAUTHIER B, ROBB M, MCPHERSON R: Cholesteryl ester transfer protein gene expression during differentiation of human preadipocytes to adipocytes in primary culture. Atherosclerosis(1999) 142(2):301-307.
44. CRANDALL DL, QUINET EM, MORGAN GA, BUSLER DE, MCHENDRY-RINDE B, KRAL JG: Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes. J. Clin. Endocrinol. Metab. (1999) 84(9):3222-3227.
45. SAMAD F, YAMAMOTO K, LOSKUTOFF DJ: Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J. Clin. Invest. (1996) 97(1):37-46.
46. OUCHI N, KIHARA S, ARITA Y et al.: Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation (1999) 100(25):2473-2476.
47. FRIED SK, RUSSELL CD, GRAUSO NL, BROLIN RE: Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J. Clin. Invest. (1993) 92(5):2191-2198.
48. KERN PA, SVOBODA ME, ECKEL RH, VAN WYK JJ: Insulin-like growth factor action and production in adipocytes and endothelial cells from human adipose tissue. Diabetes (1989) 38(6):710-717.
49. BONEY CM, MOATS-STAATS BM, STILES AD, D'ERCOLE AJ: Expression of insulin-like growth factor-I (IGF-I) and IGF-binding proteins during adipogenesis. Endocrinology (1994) 135(5):1863-1868.
50. CIANFLONE K: Acylation stimulating protein and the adipocyte. J. Endocrinol. (1997) 155(2):203-206.
51. HOTAMISLIGIL GS, SHARGILL NS, SPIEGELMAN BM: Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked resistance. Science (1993) 259(5091):87-91.
52. SCHÄFFLER A, ORSO E, PALITZSCH KD et al.: The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for familial combined hyperlipidaemia (FCH). Biochem. Biophys. Res. Commun. (1999) 260(2):416-425.
53. COOK KS, MIN HY, JOHNSON D et al.: Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve. Science (1987) 237(4813):402-405. The first adipocyte-specific complement factor identified.
54. PEAKE PW, O'GRADY S, PUSSELL BA, CHARLESWORTH JA: Detection and quantification of the control proteins of the alternative pathway of complement in 3T3-L1 adipocytes. Eur. J. Clin. Invest. (1997) 27(11)922-927.
55. CLAFFEY KP, WILKISON WO, SPIEGELMAN BM: Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. (1992) 267(23):16317-16322.
56. SMAS CM, SUL HS: Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell. (1993) 73(4):725-734.
57. LEVINE JA, JENSEN MD, EBERHARDT NL, O'BRIEN T: Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J. Clin. Invest. (1998) 101(8):1557-1564.